focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGresham Regulatory News (GHT)

Share Price Information for Gresham (GHT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 162.00
Bid: 160.00
Ask: 164.00
Change: 0.00 (0.00%)
Spread: 4.00 (2.50%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 162.00
GHT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI)

16 Apr 2024 09:43

RNS Number : 8019K
Singer Capital Markets Sec Ltd
16 April 2024
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Singer Capital Markets Securities Ltd

 

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Gresham Technologies plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Gresham Technologies plc

(d) Date dealing undertaken:

15 April 2024

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

If YES, specify which:

 

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

ORD 5p

 

 

Purchases

 

88,662

 

163.001p

 

163p

 

ORD 5p

 

 

Sales

 

100,000

 

163.5p

 

163.5p

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

Date of disclosure:

16 April 2024

Contact name:

Jennifer Bentick

Telephone number:

020 7496 3055

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERUNSWRSUUSARR
Date   Source Headline
26th Apr 20197:00 amRNSDirector's Dealing
4th Apr 20197:00 amRNSDirector's Dealing
4th Apr 20197:00 amRNSExercise of Options
29th Mar 20197:00 amRNSGrant of Options
28th Mar 20197:00 amRNSDirector's Dealing
27th Mar 20197:01 amRNSSignificant Clareti Contract with Tier 1 Bank
27th Mar 20197:00 amRNSNotice of AGM and Dividend Timetable
12th Mar 20197:00 amRNSFinal Results
7th Mar 201910:00 amRNSNotice of Results
7th Mar 20197:00 amRNSStrategic relationship with RegTek.Solutions
1st Feb 20197:00 amRNSSignificant Clareti Contract with Tier 1 Bank
29th Jan 201911:51 amRNSHolding(s) in Company
14th Jan 20197:00 amRNSSale of VME mainframe software business
7th Jan 20193:45 pmRNSHolding(s) in Company
7th Jan 20193:45 pmRNSHolding(s) in Company
4th Jan 201912:00 pmRNSClareti Contract Signed & Trading Update
17th Dec 20187:00 amRNSExtension of Clareti innovation service
6th Dec 20187:00 amRNSTrading Update
10th Oct 20187:00 amRNSTrading Update
1st Oct 20183:01 pmRNSExercise of Options
26th Sep 20187:00 amRNSStrategic fintech partnership with major bank
4th Sep 20183:35 pmRNSHolding(s) in Company
27th Jul 20187:00 amRNSExercise of Options
24th Jul 20187:00 amRNSHalf-year Report
18th Jul 20187:00 amRNSNotice of Results & Analyst Presentation
10th Jul 20187:00 amRNSHolding(s) in Company
4th Jul 201811:05 amRNSSecond Price Monitoring Extn
4th Jul 201811:00 amRNSPrice Monitoring Extension
4th Jul 20187:01 amRNSAcquisition of B2 Group
4th Jul 20187:00 amRNSTrading Update
18th May 20185:46 pmRNSHolding(s) in Company
17th May 20187:00 amRNSCapital Markets Day
10th May 20183:09 pmRNSResult of AGM
10th May 20187:00 amRNSAGM Statement
9th May 20187:00 amRNSClareti Contract Win with Global Tier 1 Bank
26th Apr 20189:26 amRNSHolding(s) in Company
23rd Apr 20187:00 amRNSGresham win Queen's Award for Enterprise
19th Apr 20187:00 amRNSExercise of Options
17th Apr 20187:00 amRNSClareti Cloud Win
6th Apr 20187:00 amRNSExercise of Options
4th Apr 20187:00 amRNSNotice of Annual General Meeting
16th Mar 201810:34 amRNSHolding(s) in Company
15th Mar 201812:57 pmRNSGrant of Options
13th Mar 20187:00 amRNSFinal Results
27th Feb 20187:00 amRNSNotice of Results & Results Presentations
5th Feb 20187:00 amRNSDirectorate Change
15th Jan 20187:00 amRNSAppointment of Chief Marketing Officer
10th Jan 201811:57 amRNSHolding(s) in Company
9th Jan 20187:00 amRNSTrading Update
29th Dec 20179:52 amRNSSignificant CTC banking contract win in Europe

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.